New combo aims to outperform standard therapy in Tough-to-Treat colon cancer
Disease control
Recruiting now
This study tests if a new combination of drugs (DSP107 and atezolizumab) works better than an existing treatment (fruquintinib) for people with advanced colorectal cancer that is microsatellite stable (MSS). About 90 adults who have already tried other therapies will be randomly …
Phase: PHASE2 • Sponsor: Kahr Bio Australia Pty Ltd • Aim: Disease control
Last updated May 17, 2026 03:09 UTC